AU2001285905A1 - 6,7-dihydro-pyrrolo(3,4-b)pyridin-5-ones with an anticonvulsive action and methods for producing the same - Google Patents
6,7-dihydro-pyrrolo(3,4-b)pyridin-5-ones with an anticonvulsive action and methods for producing the sameInfo
- Publication number
- AU2001285905A1 AU2001285905A1 AU2001285905A AU8590501A AU2001285905A1 AU 2001285905 A1 AU2001285905 A1 AU 2001285905A1 AU 2001285905 A AU2001285905 A AU 2001285905A AU 8590501 A AU8590501 A AU 8590501A AU 2001285905 A1 AU2001285905 A1 AU 2001285905A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolo
- pyridin
- dihydro
- ones
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- IPMQFUGFGHJSEI-UHFFFAOYSA-N 6,7-dihydropyrrolo[3,4-b]pyridin-5-one Chemical class C1=CC=C2C(=O)NCC2=N1 IPMQFUGFGHJSEI-UHFFFAOYSA-N 0.000 title 1
- 230000002082 anti-convulsion Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10042093A DE10042093A1 (en) | 2000-08-26 | 2000-08-26 | Anticonvulsant 6,7-dihydro-pyrrolo [3,4-d] pyridin-5-ones and process for their preparation |
| DE10042093 | 2000-08-26 | ||
| PCT/EP2001/009810 WO2002018381A1 (en) | 2000-08-26 | 2001-08-24 | 6,7-dihydro-pyrrolo[3,4-b]pyridin-5-ones with an anticonvulsive action and methods for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001285905A1 true AU2001285905A1 (en) | 2002-03-13 |
Family
ID=7653968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001285905A Abandoned AU2001285905A1 (en) | 2000-08-26 | 2001-08-24 | 6,7-dihydro-pyrrolo(3,4-b)pyridin-5-ones with an anticonvulsive action and methods for producing the same |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001285905A1 (en) |
| DE (1) | DE10042093A1 (en) |
| WO (1) | WO2002018381A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9586964B2 (en) | 2011-10-28 | 2017-03-07 | Vanderbilt University | Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1 |
| WO2013071201A1 (en) | 2011-11-11 | 2013-05-16 | Vanderbilt University | Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| US9029563B2 (en) | 2012-01-06 | 2015-05-12 | Vanderbilt University | Substituted 1-benzylindolin-2-one analogs as positive allosteric modulators of muscarinic acetylcholine M1 receptors |
| WO2013106795A1 (en) | 2012-01-12 | 2013-07-18 | Vanderbilt University | Substituted 4-(1h~pyrazol-4.yl)benzyl analogues as positive allosteric modulators of machr m1 receptors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE790408A (en) * | 1971-10-22 | 1973-04-20 | Rhone Poulenc Sa | NEW DERIVATIVES OF PYRROLO (3,4-B) PYRIDINE, THEIR PREPARATION AND THE MEDICINAL COMPOSITIONS WHICH MAKE THEM |
| OA05287A (en) * | 1975-04-07 | 1981-02-28 | Rhone Poulenc Ind | New heterocyclic compounds and their preparation. |
| US4983612A (en) * | 1989-10-05 | 1991-01-08 | American Home Products Corporation | Antihypertensive benzopyran derivatives |
| US5208247A (en) * | 1991-08-01 | 1993-05-04 | American Cyanamid Company | Pyridinium compounds which are useful as antagonists of platelet activating factor |
| ATE182332T1 (en) * | 1994-06-16 | 1999-08-15 | Pfizer | PYRAZOLO AND PYRROLOPYRIDINES |
-
2000
- 2000-08-26 DE DE10042093A patent/DE10042093A1/en not_active Withdrawn
-
2001
- 2001-08-24 AU AU2001285905A patent/AU2001285905A1/en not_active Abandoned
- 2001-08-24 WO PCT/EP2001/009810 patent/WO2002018381A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE10042093A1 (en) | 2002-03-07 |
| WO2002018381A1 (en) | 2002-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001259707A1 (en) | 6,5-fused bicyclic heterocycles | |
| AU4467801A (en) | Chlamydospores and process for producing the same | |
| AU2002349477A1 (en) | Bicyclic derivative, process for producing the same, and use | |
| AU2001259402A1 (en) | Cluster membership monitor | |
| AU5469701A (en) | Surface, method for the production thereof and an object provided with said surface | |
| AU3463400A (en) | Improved compact generator, light-emitting wheel having the same, and manufacturing method therefor | |
| AU2002213273A1 (en) | Stenoprophiluric matrices, and methods of making and using the same | |
| AU7451300A (en) | Thermoplastic elastomer, use thereof, and process for producing the same | |
| AU2002231676A1 (en) | Triazolopyrimidines | |
| AU2001276295A1 (en) | Electric component, method for the production thereof, and its use | |
| AU2002221753A1 (en) | Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same | |
| AU2001292320A1 (en) | Benzylamine compound, process for producing the same, and intermediate therefor | |
| AU2002219664A1 (en) | Microorganism Producing L-Lysine And Processes For Producing L-Lysine Using The Same | |
| AU2001246536A1 (en) | Polyamide nucleic acid derivatives, agents and methods for producing the same | |
| AU2001266176A1 (en) | Methods | |
| AU2002227966A1 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof | |
| AU2001285905A1 (en) | 6,7-dihydro-pyrrolo(3,4-b)pyridin-5-ones with an anticonvulsive action and methods for producing the same | |
| AU2001286188A1 (en) | Tricyclic heterocyclic compound, process for producing the same, and use thereof | |
| IL156162A0 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof. | |
| AU2002225790A1 (en) | Analgesic diazabicyclo(4.3.0)nonanes | |
| AU2001242742A1 (en) | Copper-tolerant yeast and pectinase produced by the copper-tolerant yeast | |
| AU2001274060A1 (en) | Electric component and method for producing the same | |
| AU2001242750A1 (en) | Novel protein, process for producing the same and use thereof | |
| AU2002222344A1 (en) | Triazolopyrimidines | |
| AU2001250536A1 (en) | Methods |